Interest in CBD is “off the charts,” but those mulling the regulatory path forward for the hottest functional ingredient of the moment might be well advised to consider how other cannabinoids will fit into the regulatory framework going forward, says...
In a development reflective of the rapidly developing hemp and cannabis markets, research firm BDS Analytics has announced $7 million in new financing.
Colorado Gov. Jared Polis said the state intends to maintain its lead in the hemp industry by putting the full weight of state government behind its farmers and extractors. The state has taken a lead in shipping hemp plants and seeds to some Latin American...
FDA needs to act quickly on CBD regulations before a rapidly developing patchwork quilt of new rules promulgated in lower jurisdictions unduly complicates the situation.
The rollout of New Age Beverages’ CBD-infused beverages has been delayed owing to the regulatory uncertainty over CBD, which makes navigating the territory “as murky as the Strait of Hormuz,” CEO Brent Willis told analysts yesterday.
A key element of the CBD debate will be determining best practices of when and how to measure the THC content of products, said an expert with long experience in the botanicals field.
LifeScienceRisk (LSR) has launched a new cannabis program for the booming category, with coverage for all stages of the chain, from growers and processors right through to retail stores.
Bod Australia has stated that the absence of a clear pathway to market for its CBD products explains why APAC is “not yet on the radar” for its recently announced distribution deal with NewH2.
In an editorial published yesterday former FDA Commissioner Scott Gottlieb said the agency needs to act quickly on CBD, but must not compromise on its mission of safety in doing so.
The authors of a guest editorial published by the American Botanical Council have proposed a regulatory structure for cannabis products that relies on federal support and coordination for state initiatives.
Europe’s cannabidiol food and supplements market was on display at a recent CBD expo in Berlin, with CBD supplement and cosmetic manufacturers reporting impressive margins in a controversial category defined by booming sales and baffling regulations.
FDA said today it will have an update on a new regulatory structure for CBD by early fall. The announcement came via a press release on another warning issued to a CBD marketer making illegal disease claims.
